Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 7:10 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2545–2568 of 21,046 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Aphasia, Stroke, Stroke Rehabilitation
Interventions: Semantically-focused therapy tasks, Phonologically-focused therapy tasks; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 21 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Major Depressive Disorder
Interventions: Active Accelerated rTMS Treatment, Sham Accelerated rTMS Treatment; Device
Lead sponsor: NeuroQore Inc.; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Campbell, California • Sunnyvale, California

Conditions: HCV Infection
Interventions: GS-9450, Placebo; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 307 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 51
States / cities: Phoenix, Arizona • Tucson, Arizona • Anaheim, California + 48 more

Conditions: Metastatic Breast Cancer
Interventions: Enzalutamide, Mifepristone, TPC; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 12
States / cities: Birmingham, Alabama • San Francisco, California • Chicago, Illinois + 9 more

Conditions: Hearing Loss, Age-Related
Interventions: Consult Model, Engage Model; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 60 Years and older
Enrollment: 684 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Food Insecurity in Post Partum Women
Interventions: FBM-In person, FBM-Virtual, home delivered food boxes; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Austin, Texas • Houston, Texas

Conditions: Pancreatic Adenocarcinoma, Borderline Resectable Adenocarcinoma of the Head of the Pancrease
Interventions: radiation therapy, surgery, mFOLFIRINOX, FOLFOX; Radiation · Procedure · Drug
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2016
U.S. locations: 154
States / cities: Mobile, Alabama • Antioch, California • Berkeley, California + 122 more

Conditions: Obstructive Sleep Apnea
Interventions: uvulopalatopharyngoplasty with or without sutures; Procedure
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 21 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Attention Difficulties
Interventions: Social Media Abstention; Behavioral
Lead sponsor: New York Institute of Technology; Other
Eligibility: 18 Years to 30 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Old Westbury, New York

Conditions: Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy, Autosomal Recessive Stargardt Disease 1 (ABCA4-related)
Interventions: ALK-001, Placebo; Drug
Lead sponsor: Alkeus Pharmaceuticals, Inc.; Industry
Eligibility: 8 Years to 70 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 14
States / cities: Phoenix, Arizona • Los Angeles, California • Aurora, Colorado + 11 more

Conditions: Pain
Interventions: Fentanyl, oxycodone/acetaminophen; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Smoking, Nicotine Dependence
Interventions: Bupropion; Drug
Lead sponsor: Henry Kranzler; Other
Eligibility: 18 Years and older · Female only
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 3
States / cities: Newark, Delaware • Philadelphia, Pennsylvania

Conditions: Acute Respiratory Failure
Interventions: Ketamine, Sedative drug regimen; Drug · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Psoriasis
Interventions: Group #2 (Intervention), Group #3 (Intervention); Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Stage IV or Recurrent Carcinoma or Sarcoma
Interventions: Complete Surgical Removal, Stereotactic Radiosurgery, Ablative external beam radiation dose, Subtotal surgical removal plus ablative radiation dose, Radioembolization; Procedure · Radiation
Lead sponsor: Rocky Mountain Cancer Centers; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2018
U.S. locations: 4
States / cities: Aurora, Colorado • Boulder, Colorado • Littleton, Colorado + 1 more

Conditions: Aphasia, Spatial Neglect, Stroke
Interventions: Prism Adaptation Treatment; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Syphilis, Early Syphilis
Interventions: Cefixime 400 milligram Oral Capsule [Suprax], Benzathine Penicillin G; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 10
States / cities: Beverly Hills, California • Los Angeles, California • Oakland, California + 3 more

Conditions: Lymphoma, Childhood Lymphoma, Solid Tumor, Childhood Solid Tumor, Neuroblastoma, Ewing Sarcoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Rhabdomyosarcoma, Soft Tissue Sarcoma, Medulloblastoma, Germ Cell Tumor, Wilms Tumor, Brain Neoplasms, Medulloblastoma, Childhood, Neuroectodermal Tumors, Primitive
Interventions: Genistein, Placebo; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 1 Year to 21 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Age 65 and Older, Strength Training
Interventions: Strength Training Program, Usual Care; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 65 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Snoring, Strep Throat
Interventions: Antibiotic; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: Up to 17 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Limited English Proficiency
Interventions: Web based educational modules, mobile video interpreting (mVI) access; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: Not listed
Enrollment: 6,669 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Tourette Syndrome
Interventions: Continuous DBS, Responsive Brain Stimulation (RBS Setting); Device
Lead sponsor: University of Florida; Other
Eligibility: 21 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Healthy Participants, Pharmacokinetic Study
Interventions: AGA2118; Drug
Lead sponsor: Angitia Incorporated Limited; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Glendale, California

Conditions: Leptomeningeal Metastasis of Breast Cancer
Interventions: Not listed
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Weeks and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland

Search by objective public record fields.

Telerehabilitation for Aphasia (TERRA)

NQ Square TMS for Major Depressive Disorder: One Day, Three Sessions in Adults

Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Hearing for Communication and Resident Engagement

Enhancing Food as Medicine Interventions for Food Insecure Postpartum Women in Central Texas

Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

Study of Effects of Sutures on Results of Palate Surgery for Obstructive Sleep Apnea

Effect of a Week-long Social Media Abstention on Sustained Attention Functions

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease

Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury

Placebo-controlled Trial of Bupropion for Smoking Cessation in Pregnant Women

Pharmacokinetic Alterations During ECMO

A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis

Definitive Therapy for Oligometastatic Solid Malignancies

Prism Adaptation in Left Brain Stroke

Cefixime for Alternative Syphilis Treatment

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

Band Together: Randomized Control Trial

Comparing Healthcare Utilization Between Adenotonsillectomy Patients With and Without Postoperative Antibiotic Use

Mobile Video Interpretation to Optimize Communication Across Language Barriers

Tourette Syndrome Deep Brain Stimulation

An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

Study in Patients With Breast Cancer Leptomeningeal Metastasis